Report generated from BNF provided by FormularyComplete ( Accessed TA Number. Title Formulary Status Section

Similar documents
Report generated from MPH Formulary provided by FormularyComplete ( Accessed Formulary Status. TA Number.

BNF 9: Blood and Nutrition

Chapter 9 Nutrition and Blood

Chapter 9 Nutrition and Blood

9. Nutrition and blood

Medicines Formulary Blood and electrolyte disorders, and vitamin deficiencies

Medicines Formulary Blood and electrolyte disorders, and vitamin deficiencies

Nutrition 1 1. Total parenteral nutrition (TPN) 2 2. Enteral nutrition 2 3. Coeliac disease 3

9: Nutrition and blood

BNF CHAPTER 9: NUTRITION & BLOOD

First line drugs Second line drugs Specialist drugs Hospital only drugs

Medicines for anaemia and mineral bone disease

Kent Kidney Care Centre: Medicines prescribed for people with chronic kidney disease

Kidney damage with normal or increased GFR Kidney damage with mild reduction in GFR

Contents. Authors Name: Christopher Wong: Consultant Nephrologist Anne Waddington: Renal Pharmacist Eimear Fegan : Renal Dietitian

codex alimentarius commission

NOTTINGHAMSHIRE AREA PRESCRIBING COMMITTEE SHARED CARE PROTOCOL AGREEMENT

Seven Easy Steps To Assess Non-Compliance Of A Food Supplement

Costing report: Erythropoiesisstimulating

Clinical Guideline Bone chemistry management in adult renal patients on dialysis

Chronic Kidney Disease Mineral Bone Disease

Common Medication for People Receiving Haemodialysis

Haemotonics (Agents Used in Anemias; Hematopoietic and Growth Factors) Dr Laith M Abbas Al-Huseini M.B.Ch.B, M.Sc., M.Res., Ph.D.

Section 8.4 Special Dilutions

VITAMIN D DEFICIENCY IN CHILDREN AND ADULTS: TREATMENT AND PROPHYLAXIS GUIDELINE

Drugs Used in Anemia

Shân Edwards Clinical Pharmacist Royal Devon & Exeter Hospital November 2012

D.K.M COLLEGE FOR WOMEN (AUTONOMOUS) VELLORE-1 DEPARTMENT OF FOODS AND NUTRITION ESSENTIAL OF MICRO NUTRIENTS

GUIDANCE NOTES. DIETETIC RISK ASSESSMENT FOR REFEEDING RECOMMENDED MEAL PLANS When commencing re-feeding: NICE (2006)

***II POSITION OF THE EUROPEAN PARLIAMENT

Official Journal of the European Communities

Medibios Laboratories Private Limited, India Nutraceutical / OTC & Cosmetics product List Product Description

FM-IN-FC-01 Rev.1. PDF processed with CutePDF evaluation edition

Greater Manchester Guidelines on the Management of Chronic Kidney Disease - Mineral Bone Disorder (CKD-MBD)

Product Information:

Medicare Parts B/D Coverage Issues

PROFESSIONAL INFORMATION

Prescribing Guidelines Prescribing arrangement for the management of patients transferring from Secondary Care to Primary Care

Northern Treatment Advisory Group

Health Food Raw Materials Directory (First Batch)

COMMON MEDICINES USED IN CKD CHRONIC KIDNEY DISEASE

Product Nutrition Information

Kimberly Tierney Bio-Nutrition

National Institute for Health and Care Excellence

Post Consumer Brands. Alpha-Bits Cereal January, Nutrition Facts Serving Size: 3/4 Cup (27g) Servings Per Package: Varies by Size

CAUTION: You must refer to the intranet for the most recent version of this procedural document.

NUTRITION FACTS BERRY. Nutrition Facts Serving Size: 1 pouch (2.08 oz/59g) [makes 9 fl oz prepared] Servings Per Container: 14

Chronic Kidney Disease Mineral and Bone Disorder (CKD-MBD) Dietetic Management Protocol

See Important Reminder at the end of this policy for important regulatory and legal information.

Velphoro (sucroferric oxyhydroxide)

FOOD SAFETY ACT (ACT NO. XIV OF 2002) Food Supplements Regulations 2003

6 ESSENTIAL NUTRIENTS PART II VITAMINS MINERALS WATER

Introduction The Role of the Kidneys Drugs used in Renal Disease Drugs and Dialysis Renal Pharmacy Team

Scottish Medicines Consortium

TECHNICAL INFORMATION

Drug Shortages with Parenteral Nutrition

Chapter 28. Media Directory. Hematopoiesis. Regulation of Hematopoiesis. Erythropoietin. Drugs for Hematopoietic Disorders

CHANGES YOU AND YOUR STAFF NEED TO KNOW ABOUT

16% HOG RATION Feed as a Complete Growing & Finishing Ration

CG1339. Version: Renal Services Group. Approving forum (QIPS or equivalent):

Nottingham Renal and Transplant Unit

ferric carboxymaltose 50mg iron/ml solution for injection/infusion (Ferinject ) SMC No. (463/08) Vifor Pharma UK Ltd

HORSE FEED. Available in 50# Bags

ferric carboxymaltose 50mg iron/ml solution for injection/infusion (Ferinject ) SMC No. (463/08) Vifor Pharmaceuticals

NHS Grampian Staff Guideline for the Management of Acute Hypokalaemia in Adults

Water. Nutrition Facts Serving Size 20 fl oz (591 ml) Servings Per Container 1. Amount Per Serving Calories 0 Calories from Fat 0

Product Information: Glucerna Therapeutic Nutrition Shake

This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents

Ensuring Safe Management of Parenteral Nutrition During Drug Shortages: Strategies and Protocols for Enabling Clinician Success

PACKAGE LEAFLET: INFORMATION FOR THE USER. SODIPHOS 22mEq / 10ml Concentrate for solution for infusion. Disodium phosphate dihydrate

Multi-Vitamin PART OF YOUR ESSENTIALS PACK

Ingredient & Nutritional Information for Total Diet Replacement products

Nutritional Information

Technology appraisal guidance Published: 26 November 2014 nice.org.uk/guidance/ta323

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 19 October 2011

PROJECT WOMEN S ANAEMIA. by My HealthWorks. Associate Member. 125A, 2nd Floor, Shahpur Jat, New Delhi ,

Product Information: Similac For Spit-Up

Product Information: Nepro with Carb Steady

Product Information: Phenex -1

Product Information: PediaSure Grow & Gain

Product Information: Tyrex -1

EFFECTIVE SHARE CARE AGREEMENT

Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Dietetic Management Protocol

Safe and effective prescribing of nutrition: the impact of dietitian prescribing rights in New Zealand

Product Information: PediaSure (Institutional)

Product Information: Propimex -1

Community provisions, relevant national rules may apply without prejudice to the provisions of the Treaty.

Product Information: Ketonex -1

Product Information: EleCare Jr

Purpose of the Guideline

SUMMARY OF PRODUCT CHARACTERISTICS. Synthamin 14, 8.5% Amino Acid Intravenous Infusion

Hematopoiesis, The hematopoietic machinery requires a constant supply iron, vitamin B 12, and folic acid.

Disclosures. Topics. Staging and GFR. K-DOQI Staging of Chronic Kidney Disease. Definition of Chronic Kidney Disease. Chronic Kidney Disease

Stability of micronutrients in PN what is known and what can be claimed? Prof. Mike.Allwood Pharmacy Consultant

PROFESSIONAL INFORMATION

Product Information: Ensure Plus Therapeutic Nutrition

Product Information: Similac Expert Care Alimentum

Vitamins. Vitamins (continued) Lipid-Soluble Vitamins (A, D, E, K) Vitamins Serve Important Roles in Function of Body

Transcription:

Report generated from BNF provided by FormularyComplete (www.pharmpress.com). Accessed 16 02 2017 Title Formulary Status Section TA Number TA Link Annotation Abidec Adcal-D3 Addiphos Additrace 9.6 Vitamins->9.6.7 Multivitamin 9.6 Vitamins->9.6.4 Vitamin D->COLECALCIFEROL->With calcium 9.3 Intravenous nutrition->supplementary 9.3 Intravenous nutrition->supplementary ALFACALCIDOL 9.6 Vitamins->9.6.4 Vitamin D Anaemias and some other blood disorders ASCORBIC ACID 9.6 Vitamins->9.6.3 Vitamin C Bicarbonate and lactate Binocrit Calcichew Electrolytes and water anaemias->erythropoietins->epoetin ALFA, BETA, and ZETA->Epoetin alfa supplements->calcium SALTS->Oral CALCITRIOL 9.6 Vitamins->9.6.4 Vitamin D Calcium and magnesium 9.5 Minerals

Calcium Chloride supplements->calcium SALTS->Parenteral Calcium Gluconate supplements->calcium SALTS->Oral Calcium Gluconate supplements->calcium SALTS->Parenteral Calcium Resonium Oral for fluid and potassium->management of hyperkalaemia->polystyrene SULFONATE RESINS CALCIUM SALTS supplements Calcium supplements magnesium CINACALCET magnesium->9.5.1.2 Hypercalcaemia and hypercalciuria TA117 http://www.nice.org.uk/ta117 Not stocked in pharmacy as PAH does not comission the service requiring use of this drug. CosmoFer anaemias->9.1.1.2 Parenteral iron->iron DEXTRAN DARBEPOETIN ALFA anaemias->erythropoietins TA323 http://www.nice.org.uk/ta323

Desferal anaemias->iron overload->desferrioxamine MESILATE DESFERRIOXAMINE MESILATE anaemias->iron overload Dioralyte Oral for fluid and electrolyte imbalance->9.2.1.2 Oral sodium and water->oral rehydration therapy (ORT)->ORAL REHYDRATION SALTS (ORS)->UK formulations Drugs used in hypoplastic, haemolytic, and renal anaemias disorders Drugs used in megaloblastic anaemias disorders Drugs used in metabolic disorders 9.8 Metabolic disorders Drugs used in neutropenia disorders Electrolytes and water electrolyte imbalance ELTROMBOPAG disorders->9.1.4 Drugs used in platelet disorders->idiopathic thrombocytopenic purpura TA293 http://www.nice.org.uk/ta293 Approved according to NICE technology appraisal guidance 293 Enteral nutrition 9.4 Oral nutrition

Epoetin alfa anaemias->erythropoietins->epoetin ALFA, BETA, and ZETA EPOETIN ALFA, BETA, and ZETA anaemias->erythropoietins TA323 http://www.nice.org.uk/ta323 Eprex anaemias->erythropoietins->epoetin ALFA, BETA, and ZETA->Epoetin alfa ERGOCALCIFEROL 9.6 Vitamins->9.6.4 Vitamin D Erythropoietins Ferrograd FERROUS FUMARATE FERROUS SULFATE Ferrous Sulfate Fluids and electrolytes anaemias anaemias->9.1.1.1 Oral iron->ferrous SULFATE->Modified-release anaemias->9.1.1.1 Oral iron anaemias->9.1.1.1 Oral iron anaemias->9.1.1.1 Oral iron->ferrous SULFATE

FOLIC ACID Folic Acid GELATIN Gelofusine GLUCOSE Glucose Intravenous Infusion Granocyte HYDROXOCOBALAMIN Hydroxocobalamin disorders->9.1.2 Drugs used in megaloblastic anaemias disorders->9.1.2 Drugs used in megaloblastic anaemias->folic ACID electrolyte imbalance->9.2.2.2 Plasma and plasma substitutes->plasma substitutes electrolyte imbalance->9.2.2.2 Plasma and plasma substitutes->plasma substitutes->gelatin glucose glucose->glucose disorders->9.1.6 Drugs used in neutropenia->lenograstim disorders->9.1.2 Drugs used in megaloblastic anaemias disorders->9.1.2 Drugs used in megaloblastic anaemias->hydroxocobalamin

HYDROXYETHYL STARCH Idiopathic thrombocytopenic purpura Intravenous glucose Intravenous nutrition Intravenous potassium Intravenous sodium Iron-deficiency anaemias IRON DEXTRAN Iron overload Kay-Cee-L LENOGRASTIM electrolyte imbalance->9.2.2.2 Plasma and plasma substitutes->plasma substitutes disorders->9.1.4 Drugs used in platelet disorders Electrolytes and water Electrolytes and water Electrolytes and water disorders anaemias->9.1.1.2 Parenteral iron anaemias Oral for fluid and potassium->potassium CHLORIDE disorders->9.1.6 Drugs used in neutropenia

Magnesium magnesium MAGNESIUM SULFATE magnesium->9.5.1.3 Magnesium Management of hyperkalaemia Oral for fluid and potassium Metabolic disorders Mimpara magnesium->9.5.1.2 Hypercalcaemia and hypercalciuria->cinacalcet Not stocked in pharmacy as PAH does not comission the service requiring its use. Minerals Minijet Sodium Bicarbonate Electrolytes and water->bicarbonate and lactate->sodium BICARBONATE Modified-release anaemias->9.1.1.1 Oral iron->ferrous SULFATE Modified-release Oral for fluid and potassium->potassium CHLORIDE Multivitamin 9.6 Vitamins NeoRecormon anaemias->erythropoietins->epoetin ALFA, BETA, and ZETA->Epoetin beta

Nplate disorders->9.1.4 Drugs used in platelet disorders->idiopathic thrombocytopenic purpura->romiplostim http://www.nice.org.uk/guidance/ta221/guidance/pdf ">To be used in accordance with NICE Guideline http://www.nice.org.uk/guidance/ta221/guidance/pdf Oral iron anaemias Oral nutrition Oral potassium Oral for fluid and electrolyte imbalance Oral supplements->calcium SALTS Oral for fluid and electrolyte imbalance 9.2 Fluids and electrolytes ORAL REHYDRATION SALTS (ORS) Oral for fluid and electrolyte imbalance->9.2.1.2 Oral sodium and water->oral rehydration therapy (ORT) Oral rehydration therapy (ORT) Oral for fluid and electrolyte imbalance->9.2.1.2 Oral sodium and water Oral sodium and water Oral for fluid and electrolyte imbalance Parenteral supplements->calcium SALTS Parenteral for fluid and electrolyte imbalance 9.2 Fluids and electrolytes

Peditrace PENICILLAMINE Phosphate-Sandoz Phosphate supplements 9.3 Intravenous nutrition->supplementary 9.8 Metabolic disorders->9.8.1 Drugs used in metabolic disorders->wilson's disease 9.5 Minerals->9.5.2 Phosphorus->9.5.2.1 Phosphate supplements 9.5 Minerals->9.5.2 Phosphorus Phosphorus 9.5 Minerals Plasma and plasma substitutes Plasma substitutes POLYSTYRENE SULFONATE RESINS POTASSIUM CHLORIDE POTASSIUM CHLORIDE Potassium Chloride and Glucose Intravenous Infusion electrolyte imbalance electrolyte imbalance->9.2.2.2 Plasma and plasma substitutes Oral for fluid and potassium->management of hyperkalaemia Oral for fluid and potassium potassium potassium->potassium CHLORIDE

Potassium Chloride and Sodium Chloride Intravenous Infusion potassium->potassium CHLORIDE Potassium Chloride Concentrate, Sterile potassium->potassium CHLORIDE Potassium Chloride, Sodium Chloride, and Glucose Intravenous Infusion potassium->potassium CHLORIDE Pregaday anaemias->9.1.1.1 Oral iron->ferrous FUMARATE->With folic acid Resonium A Oral for fluid and potassium->management of hyperkalaemia->polystyrene SULFONATE RESINS Revolade disorders->9.1.4 Drugs used in platelet disorders->idiopathic thrombocytopenic purpura->eltrombopag Approved according to NICE Guidance ROMIPLOSTIM disorders->9.1.4 Drugs used in platelet disorders->idiopathic thrombocytopenic purpura TA221 http://www.nice.org.uk/ta221 http://www.nice.org.uk/guidance/ta221/guidance/pdf ">To be used in accordance with NICE Guideline http://www.nice.org.uk/guidance/ta221/guidance/pdf Sando-K Oral for fluid and potassium->potassium CHLORIDE

Sandocal Slow-K Slow Sodium SODIUM BICARBONATE Sodium Bicarbonate Intravenous Infusion SODIUM CHLORIDE SODIUM CHLORIDE Sodium Chloride and Glucose Intravenous Infusion supplements->calcium SALTS->Oral Oral for fluid and potassium->potassium CHLORIDE->Modified-release Oral for fluid and electrolyte imbalance->9.2.1.2 Oral sodium and water->sodium CHLORIDE Electrolytes and water->bicarbonate and lactate Electrolytes and water->bicarbonate and lactate->sodium BICARBONATE Oral for fluid and electrolyte imbalance->9.2.1.2 Oral sodium and water sodium sodium->sodium CHLORIDE->With other ingredients

Sodium Chloride Intravenous Infusion SODIUM FEREDETATE Sodium Lactate Intravenous Infusion, Compound Solivito N Supplementary Sytron sodium->sodium CHLORIDE anaemias->9.1.1.1 Oral iron sodium->sodium CHLORIDE->With other ingredients 9.3 Intravenous nutrition->supplementary 9.3 Intravenous nutrition anaemias->9.1.1.1 Oral iron->sodium FEREDETATE THIAMINE 9.6 Vitamins->9.6.2 Vitamin B group UK formulations Oral for fluid and electrolyte imbalance->9.2.1.2 Oral sodium and water->oral rehydration therapy (ORT)->ORAL REHYDRATION SALTS (ORS) Vitamin A 9.6 Vitamins VITAMIN A 9.6 Vitamins->9.6.1 Vitamin A Vitamin B group 9.6 Vitamins Vitamin C 9.6 Vitamins Vitamin D 9.6 Vitamins Vitamin E 9.6 Vitamins

Vitamin K 9.6 Vitamins Vitamins Vitamins Vitlipid N Water Water for Injections Wilson's disease With calcium With other ingredients With vitamin D 9.6 Vitamins->9.6.7 Multivitamin 9.3 Intravenous nutrition->supplementary Electrolytes and water Electrolytes and water->water 9.8 Metabolic disorders->9.8.1 Drugs used in metabolic disorders 9.6 Vitamins->9.6.4 Vitamin D->ERGOCALCIFEROL sodium->sodium CHLORIDE supplements->calcium SALTS Zinc 9.5 Minerals ZINC SULFATE 9.5 Minerals->9.5.4 Zinc ANAGRELIDE disorders->9.1.4 Drugs used in platelet disorders->essential thrombocythaemia Consultant use only in secondary care Drugs used in platelet disorders disorders Endorsed by the Drug and Therapeutics Committee in line with London Cancer Network. Patients should be treated if they fulfill the criteria.

Ferinject anaemias->9.1.1.2 Parenteral iron->ferric CARBOXYMALTOSE Second line use in patients not tolerating Cosmofer. To be used with caution in patients with a history of allergic disorders including asthma. FILGRASTIM disorders->9.1.6 Drugs used in neutropenia For Dr. Singer\'s clinical trial use only Fosrenol 9.5 Minerals->9.5.2 Phosphorus->9.5.2.2 Phosphate-binding agents->lanthanum Hertfordshire Medicines Management Committee (HMMC) Sept 2014 - Amber Status - Recommended for prescribing by specialist and primary care in the presence of appropriate shared care guidance agreed with commissioners in hyperphosphataemia associated with chronic kidney diease in adult dialysis patients and in adult patients not on dialysis. Red status - recommended for restricted prescribing by specialists ONLY for hyperphosphataemia associated with chronic kidney disease in children with or without dialysis. LANTHANUM 9.5 Minerals->9.5.2 Phosphorus->9.5.2.2 Phosphate-binding agents Hertfordshire Medicines Management Committee (HMMC) Sept 2014 - Amber Status - Recommended for prescribing by specialist and primary care in the presence of appropriate shared care guidance agreed with commissioners in hyperphosphataemia associated with chronic kidney diease in adult dialysis patients and in adult patients not on dialysis. Red status - recommended for restricted prescribing by specialists ONLY for hyperphosphataemia associated with chronic kidney disease in children with or without dialysis. Neupogen disorders->9.1.6 Drugs used in neutropenia->filgrastim For Dr. Singer\'s clinical trial use only Renagel 9.5 Minerals->9.5.2 Phosphorus->9.5.2.2 Phosphate-binding agents->sevelamer HYDROCHLORIDE Hertfordshire Medicines Mangement Committee (HMMC) Sept 2014 -Amber Status - Recommended for prescribing by specialist and primary care in the presence of appropriate shared care guidelines agreed with commissioners for hyperphosphataemia associated with chronic kidney diease in adult patients on or not on dialysis. Red status - recommended for restricted prescribing by specialists ONLY for hyperphosphataemia associated with chronic kidney disease in children on or not on dialysis. SEVELAMER HYDROCHLORIDE 9.5 Minerals->9.5.2 Phosphorus->9.5.2.2 Phosphate-binding agents Hertfordshire Medicines Mangement Committee (HMMC) Sept 2014 -Amber Status - Recommended for prescribing by specialist and primary care in the presence of appropriate shared care guidelines agreed with commissioners for hyperphosphataemia associated with chronic kidney diease in adult patients on or not on dialysis. Red status - recommended for restricted prescribing by specialists ONLY for hyperphosphataemia associated with chronic kidney disease in children on or not on dialysis. Xagrid disorders->9.1.4 Drugs used in platelet disorders->essential thrombocythaemia->anagrelide Endorsed by the Drug and Therapeutics Committee in line with London Cancer Network. Patients should be treated if they fulfill the criteria.